Hello, Welcome to Shine Consultant !
Summit & Event Shine Speaker Bureau Shine Advisor Shine Event Service
  • Summit & Event :
    With field research of markets and industries which is analyzed from a global strategic perspective by our professional teams, as well as hot topics which interest leadership and management, Shine Consultant provides you with one-stop platform of dialogue, practice -sharing and social network!
  • Shine Speaker Bureau:
    Committed to provide keynote speakers, executive learning masterclasses and boardroom advisory for global enterprises and institutions, each service provides a deeper and more interactive experience, especially for small, selected audiences and key individuals. We have the resources of the most influential business leaders and experts, who are the most outstanding representatives in their fields. Our team consists of experienced speech and event managers, and we focus on building long-term and in-depth partnerships.
  • Shine Advisor:
    As world-class insight network, we connects clients-decision makers with vetted subject matter experts-advisors. Our clients leverage the insights and perspectives shared by our advisors to stay informed and make better business decisions.We have over 600,000 Shine Advisors in 20 industries, which continues to grow every day.
  • Shine Event Service:
    Committed to be the world's most professional provider of industrial Summit & Event. We provide one-stop professional services, including investigating and planning, on-demand inviting, marketing and promoting, operating, project management, live& digital conference, each service is performed by an experienced professional team matched with long-term industrial resources. We focus on establishing long-term and in-depth partnerships.
Guest Information
Mingqiang Zhang
Mingqiang Zhang

VP of Global R&D\Head of Asia R&D



Dr Ming-Qiang Zhang is corporate Vice President of Research & Development and a member of Senior Leadership Team in Translational Science at Amgen. He leads Amgen’s Asia R&D as the Head of the company’s R&D Center in Shanghai, China and General Manager / Legal Representative of Amgen BioPharmaceutical R&D (Shanghai) Co., Ltd. He also serves as chair of the R&D Working Group of the R&D-based Pharmaceutical Association in China (RDPAC), and Vice-Chairman of the Med Chem Committee of the Chinese Pharmaceutical Association (CPA) as well as an adviser to a number of local government and industry organizations on biopharmaceuticals. He has >20 years of R&D experience and led the discovery of multiple candidate drugs progressed to approval or clinical development for the treatment of CNS, cancer, inflammatory and infectious diseases, including Merck's first-in-class muscle relaxant reversing agent BRIDION® (sugammadex). He is co-author / co-inventor of >100 scientific publications / patents, a Fellow of the Royal Society of Chemistry and a scientific advisory board member of several scientific publications incl. MedChemComm, Current Drug Discovery, Chinese J Med Chem, BAO J Pharm Sci. His scientific achievement has been recognized by a number of prestigious awards including the Malcolm Campbell Memorial Prize and the Nexxus Life Science Award for Innovation. BRIDION is nominated for 2016 Prix Galien USA “Best Pharmaceutical Product” - the equivalent of the Nobel Prize in biopharmaceutical and medical technology research.

Prior to joining Amgen, Dr Zhang held a series of R&D leadership roles with increasing responsibilities in top-notch companies ranging from biotech, specialty pharma to large multi-national companies. He was corporate Vice President and Head of Asia Pacific R&D at Merck Sharp & Dohme (Merck & Co.), and served as the founding General Manager of MSD R&D (China) Co. Ltd. He also co-founded ViroChem Pharma Inc in Montreal, Canada, which was acquired by Vertex in 2009.